Briacell Therapeutics Corp Share Price

NASDAQ: BCTXZ

Small Cap

$0.22

+0.01

(+4.67%)

as on September 17, 2025 at 1:18 am IST

$₹

Briacell Therapeutics Corp Stock Performance

as on September 17, 2025 at 1:18 am IST

Day's Low
$0.17
Day's Price Range
$0.22
$0.22
22.73%
Downside
52 Week's Low
52 Week's High
$0.12
52-Week Price Range
$1.52
$0.22
45.45%
Downside
588.64%
Upside

Briacell Therapeutics Corp share price movements today

Previous Close: $0.21
Open: $0.20
Volume: 209.1K
Day's Low - High: $0.17 - $0.22
52 Week Low - High: $0.12 - $1.52

Briacell Therapeutics Corp Historical Returns

1 Month Return: -23.97 %
3 Month Return: -81.37 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Briacell Therapeutics Corp Stock Fundamentals & Key Indicators

Check Briacell Therapeutics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

10579200.00%

Briacell Therapeutics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Briacell Therapeutics Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Briacell Therapeutics Corp	NA	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Briacell Therapeutics Corp Stock's Interest Amongst Investors

Search interest for Briacell Therapeutics Corp Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-4% versus previous 30 day period

Briacell Therapeutics Corp Quarterly Profit & Loss

All numbers in Millions USD

	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Income	-11	-9	-5	-5	-7	-6
EBITDA	-9	1	-7	-5	-7	-6
Interest Expense	-	-	-	-	-	0
Depreciation	0	0	0	0	0	0
Income Before Tax	-11	1	-1	-5	-6	-6
Income Tax Expense	-	-	-	-	-	-
Net Income	-11	1	-1	-5	-6	-6
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Briacell Therapeutics Corp Annual Profit & Loss

All numbers in Millions USD

	Jul 2021	Jul 2022	Jul 2023	Jul 2024
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Income	-6	-15	-23	-33
EBITDA	-13	-26	-23	-33
Interest Expense	0	0	-	-
Depreciation	0	0	0	0
Income Before Tax	-13	-26	-20	-4
Income Tax Expense	-	-	-	-
Net Income	-13	-26	-20	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Briacell Therapeutics Corp Quarterly Cash Flow

All numbers in Millions USD

	Apr 2023	Jul 2023	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025
Net Income	-4	-2	5	-11	1	-1	-5	-6	-6
Operating Cash Flow	-5	-10	-7	-7	-5	-4	-6	-5	-7
Investing Cash Flow	-	-	-	-	0	0	0	0	0
Financing Cash Flow	0	4	-	-	-	4	11	5	14
Change in Cash	-5	-6	-7	-7	-5	0	4	0	7

Briacell Therapeutics Corp Annual Cash Flow

All numbers in Millions USD

	Jul 2016	Jul 2017	Jul 2018	Jul 2019	Jul 2020	Jul 2021	Jul 2022	Jul 2023	Jul 2024
Net Income	-1	-2	-4	-4	-4	-13	-26	-20	-4
Operating Cash Flow	-1	-1	-3	-4	-1	-7	-12	-23	-24
Investing Cash Flow	0	0	0	1	-	-	-	-	0
Financing Cash Flow	0	2	4	2	1	64	-3	3	4
Change in Cash	0	0	0	0	0	57	-16	-19	-20

Insights on Briacell Therapeutics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, BCTXZ stock has moved down by -9.5%

About Briacell Therapeutics Corp

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

Organisation	Briacell Therapeutics Corp
Headquarters	Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1
CEO	Dr. William V. Williams FCPA, M.D.
E-voting on shares	Click here to vote

Key Management of Briacell Therapeutics Corp

Name	Title
Dr. Charles Louis Wiseman FACP, M.D.	Founder, Principal Research Advisor & Member of Scientific Advisory Board
Dr. William V. Williams FCPA, M.D.	CEO, President & Director
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.	CFO & Corporate Secretary
Dr. Miguel A. Lopez-Lago Ph.D.	Chief Scientific Officer
Dr. Giuseppe Del Priore M.D., M.P.H., MPH	Chief Medical Officer

FAQs

What is Briacell Therapeutics Corp share price today?

Briacell Therapeutics Corp share price today is $0.22 as on September 17, 2025 at 1:18 am IST at the close of the market. Briacell Therapeutics Corp share today touched a day high of $0.22 and a low of $0.17.

What is the 52 week high and 52 week low for Briacell Therapeutics Corp share?

Briacell Therapeutics Corp share touched a 52 week high of $1.52 on April 25, 2025 and a 52 week low of $0.12 on August 25, 2025. Briacell Therapeutics Corp stock price today i.e. September 17, 2025 at 1:18 am IST is closed at $0.22,which is 85.48% down from its 52 week high and 83.33% up from its 52 week low.

How to invest in Briacell Therapeutics Corp Stock (BCTXZ) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Briacell Therapeutics Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Briacell Therapeutics Corp Shares that will get you 6.8182 shares as per Briacell Therapeutics Corp share price of $0.22 per share as on September 17, 2025 at 1:18 am IST.

What is the minimum amount required to buy Briacell Therapeutics Corp Stock (BCTXZ) from India?

Indian investors can start investing in Briacell Therapeutics Corp (BCTXZ) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 4:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Briacell Therapeutics Corp stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 4:38 pm IST). Based on Briacell Therapeutics Corp share’s latest price of $0.22 as on September 17, 2025 at 1:18 am IST, you will get 45.4545 shares of Briacell Therapeutics Corp. Learn more about fractional shares .